×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TARS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/24
01:29 pm
tars
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade [Yahoo! Finance]
Low
Report
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade [Yahoo! Finance]
3/23
08:46 am
tars
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus [Yahoo! Finance]
Low
Report
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus [Yahoo! Finance]
3/23
08:30 am
tars
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
Medium
Report
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
3/18
06:57 am
tars
Tarsus Pharmaceuticals (TARS) was upgraded by Lifesci Capital to "strong-buy".
Medium
Report
Tarsus Pharmaceuticals (TARS) was upgraded by Lifesci Capital to "strong-buy".
3/11
02:47 pm
tars
Tarsus Pharmaceuticals, Inc. (TARS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Tarsus Pharmaceuticals, Inc. (TARS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/9
12:27 am
tars
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Mixed Share Performance [Yahoo! Finance]
Low
Report
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Mixed Share Performance [Yahoo! Finance]
3/6
10:36 am
tars
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating [Yahoo! Finance]
Low
Report
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating [Yahoo! Finance]
2/28
01:30 am
tars
Tarsus Pharmaceuticals (TARS) was downgraded by Wall Street Zen from
Low
Report
Tarsus Pharmaceuticals (TARS) was downgraded by Wall Street Zen from
Date
Time
Symbol
Company Name
Action
%Chg
2/23/2026
04:05 pm
tars
tarsus pharmaceuticals, inc.
MISS
Report
7.8%
tarsus pharmaceuticals, inc.
11/4/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
BEAT
Report
-4.6%
tarsus pharmaceuticals, inc.
8/6/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
MISS
Report
15.2%
tarsus pharmaceuticals, inc.
5/1/2025
04:05 pm
tars
tarsus pharmaceuticals, inc.
BEAT
Report
-5.3%
tarsus pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/24
05:06 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 20 Filed by: Neervannan Seshadri
Medium
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 20 Filed by: Neervannan Seshadri
3/20
10:38 am
tars
Form 144 Tarsus Pharmaceuticals, Filed by: Neervannan Seshadri
Low
Report
Form 144 Tarsus Pharmaceuticals, Filed by: Neervannan Seshadri
3/19
07:05 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Whitfield Dianne C.
Medium
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Whitfield Dianne C.
3/19
07:05 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Wahl Bryan
Medium
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Wahl Bryan
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Mottiwala Aziz
Medium
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Mottiwala Aziz
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Lin Elizabeth Yeu
Medium
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Lin Elizabeth Yeu
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Azamian Bobak R.
Medium
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Azamian Bobak R.
3/19
07:04 pm
tars
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Farrow Jeffrey S
Medium
Report
Form 4 Tarsus Pharmaceuticals, For: Mar 17 Filed by: Farrow Jeffrey S
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: